Calcium-engaged Mechanisms of Nongenomic Action of Neurosteroids

Curr Neuropharmacol. 2017 Nov 14;15(8):1174-1191. doi: 10.2174/1570159X15666170329091935.

Abstract

Background: Neurosteroids form the unique group because of their dual mechanism of action. Classically, they bind to specific intracellular and/or nuclear receptors, and next modify genes transcription. Another mode of action is linked with the rapid effects induced at the plasma membrane level within seconds or milliseconds. The key molecules in neurotransmission are calcium ions, thereby we focus on the recent advances in understanding of complex signaling crosstalk between action of neurosteroids and calcium-engaged events.

Methods: Short-time effects of neurosteroids action have been reviewed for GABAA receptor complex, glycine receptor, NMDA receptor, AMPA receptor, G protein-coupled receptors and sigma-1 receptor, as well as for several membrane ion channels and plasma membrane enzymes, based on available published research.

Results: The physiological relevance of neurosteroids results from the fact that they can be synthesized and accumulated in the central nervous system, independently from peripheral sources. Fast action of neurosteroids is a prerequisite for genomic effects and these early events can significantly modify intracellular downstream signaling pathways. Since they may exert either positive or negative effects on calcium homeostasis, their role in monitoring of spatio-temporal Ca2+ dynamics, and subsequently, Ca2+-dependent physiological processes or initiation of pathological events, is evident.

Conclusion: Neurosteroids and calcium appear to be the integrated elements of signaling systems in neuronal cells under physiological and pathological conditions. A better understanding of cellular and molecular mechanisms of nongenomic, calcium-engaged neurosteroids action could open new ways for therapeutic interventions aimed to restore neuronal function in many neurological and psychiatric diseases.

Keywords: Calcium; central nervous system; neuropathology.; neuroprotection; neurosteroids; nongenomic action.

Publication types

  • Review

MeSH terms

  • Animals
  • Calcium / metabolism*
  • Central Nervous System / drug effects*
  • Central Nervous System / metabolism*
  • Humans
  • Neurotransmitter Agents / pharmacology*
  • Receptors, Cell Surface / drug effects
  • Receptors, Cell Surface / metabolism
  • Signal Transduction / drug effects
  • Signal Transduction / physiology
  • Synaptic Transmission / drug effects*

Substances

  • Neurotransmitter Agents
  • Receptors, Cell Surface
  • Calcium